AI and Healthcare

What can be done to reduce the cost of healthcare?—with Dr. Sanjay Juneja

Tackling healthcare costs requires both human connection and smarter use of technology. Dr. Alister Martin emphasizes the importance of trust, the power of patient navigators, and why AI is quickly becoming essential. With a focus on workforce upskilling and sustainable reimbursement models, there’s a clear path to reducing ER visits, improving outcomes, and making care more affordable.

Why is AI still so hard to implement in hospitals?—with Mika Newton

AI has the potential to transform healthcare, but adoption remains slow. Outdated IT infrastructure, strict data policies, high implementation costs, and concerns around bias and model performance all stand in the way. Scaling AI in hospitals requires more than just promising tools - it demands infrastructure that supports ongoing governance, transparency, and real-world impact.

How will AI actually change a doctor's daily work?—with Mika Newton

Healthcare is drowning in inefficiency - 80% of data is noise, and clinicians waste precious time on tasks that don’t improve patient outcomes. But AI is flipping the script. Imagine diagnosing lung cancer in seconds instead of digging through hours of records, or boosting revenue (RVUs) while actually enhancing care quality. Uncover the real barriers to AI adoption and how new platforms are cutting through vendor lock-in to make AI tools accessible in weeks, not months. From radiology to care coordination, AI isn’t just the future - it’s the lifeline healthcare needs today.

How can AI help identify ER frequent flyers?—with Dr. Sanjay Juneja

Millions of dollars are being wasted in healthcare every year—not because of a lack of resources, but because people aren’t accessing the help that already exists. AI is starting to change that. By streamlining access to underused benefit programs, AI can help patients avoid unnecessary ER visits, reduce hospital strain, and cut costs across the healthcare system. Dr. Alister Martin shares how his work at Link Health is using AI to bridge the gap between patients and public resources, with real-world results backed by recent clinical trials. It’s a powerful example of how smart technology can drive both financial and human impact in medicine.

How AI is Fixing Healthcare’s Cost Crisis—with Dr. Sanjay Juneja [Full Podcast]

Healthcare costs are rising, but AI could be the key to fixing the system. Beyond improving patient care, AI has the potential to reduce administrative burdens, streamline workflows, and lower overall costs. Dr. Alister Martin has spent years at the intersection of medicine and social change, exploring how technology can make healthcare more efficient and accessible. This conversation looks at how AI-driven solutions can address both the financial and social challenges facing the healthcare industry.

Can hospitals trust AI with sensitive patient data?—with Mika Newton

AI adoption in healthcare comes with complexities, from regulatory hurdles to the challenge of building secure, scalable systems that align with hospital needs. Finding the right balance between innovation and data privacy is key to ensuring these technologies can be effectively integrated into medical environments.

What AI native Healthtech should we pay attention to?—with Mika Newton

AI is transforming healthcare by streamlining medical workflows, enhancing drug development, and driving more efficient, data-driven solutions. Krish Ramadurai shares insights on AI-native health tech, digital pathology, and the challenges of scaling automation in biotech, highlighting the impact of technology on the future of medicine.

How do you pick the right drug assets?—with Mika Newton

Picking the right drugs is a high-stakes game. Get it right more often than the competition, and the rewards are massive. Miss a few, and you’re out. So how do top investors and biotech leaders make smart bets? Understanding what pharma actually wants, securing multiple key advocates, and strategically managing risk are all part of the playbook. From clinical-stage assets to investor-backed decision-making, this deep dive unpacks how biotech companies position themselves for success—and what separates the winners from the rest.